When the Food and Drug Administration issued its final guidance last year on clinical decision support (CDS) software, some criticized the agency for taking a much broader approach than it had laid out in its draft guidance a few years prior.
As legal experts told Medtech Insight in October 2022 after the agency published its final document, developers relying on the...